Wieslab Laboratory Services is proud to be one of the first diagnostic laboratories in Scandinavia to offer neurofilament light (NfL) testing in CSF, serum, EDTA-plasma.
With the newest addition to our technology platform, we are able to use a single molecule array digital ELISA (SIMOA) to evaluate neurofilament light chain (NfL) in CSF, serum, EDTA-plasma.
NfL is a well-known biomarker for measuring disease activity, treatment response, and prognosis in patients with neurodegenerative disorders.
Being able to test NfL levels in CSF, serum, plasma facilitates patient care.